Drew Weissman

Roberts Family Professor in Vaccine Research and Director of the Penn Institute for RNA Innovation at the Perelman School of Medicine · University of Pennsylvania Health System

Credentials: · · ·

History

University of Pennsylvania Health System
Present
Infectious Diseases Division · University of Pennsylvania Health System
Present
University of Pennsylvania Health System
Present

Infectious Disease
Lab of Immunoregulation in the National Institute of Allergy and Infectious Disease
1990–1992
National Institutes of Health
Internal Medicine
Beth Israel Deaconess Medical Center
1987–1990
University
Boston University School of Medicine
1983–1987
Brandeis University
1977–1981
Brandeis University
1979–1981

Research

mRNA vaccines - a new era in vaccinology
Review · Nature Reviews Drug Discovery · 2018 · Last of 4 authors · 3,382 citations
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA
Immunity · 2005 · Last of 4 authors · 2,075 citations
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability
Molecular Therapy · 2008 · Last of 7 authors · 1,491 citations

Barton Haynes
26 papers · 8 as a fellow
Anthony Fauci
19 papers
Gregory Bisson
17 papers
Rohan Palanki
13 papers · 2 as a resident
Jacob Brenner
11 papers · 1 as a fellow
Erol Fikrig
8 papers
Harvey Friedman
8 papers
Carl June
7 papers
Edward Kreider
7 papers
James Wilson
7 papers
Andrew Steenhoff
6 papers
Robert Gross
6 papers

Grants

Innovative Strategies to Inhibit Humoral Immunity in Renal Xenotransplantation
National Institute of Allergy and Infectious Diseases · R01
PI · $1.3M · University of Pennsylvania
2026–2031
Dissecting Functional Decompensation of End-Stage Liver Disease and the Mechanism and Impact of Transcription Factors on Long-Term Functional Reprogramming
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $814.5K · University of Pittsburgh at Pittsburgh
2026–2030
Individualized HIV Curative Combination Strategy Against Persistent HIV on ART
National Institute of Allergy and Infectious Diseases · UM1
PI · $6.9M · Wistar Institute
2025–2030
Immune Repertoire Remodeling Following B Cell-Targeted CAR T Cells for Induction of Renal Allograft Tolerance in Non-Human Primates
National Institute of Allergy and Infectious Diseases · R01
PI · $3.3M · University of Pennsylvania
2025–2030